Ocean State Labs to Open as Rhode Island's First Life Science Incubator

September 24, 2025
The Rhode Island Life Science Hub announced the foundational members of Ocean State Labs, the state's first life science incubator, set to open in early 2026.

The Rhode Island Life Science Hub, in collaboration with Governor Dan McKee, has announced the foundational members of Ocean State Labs, the state's first life science incubator. Announced in a press release, the incubator is set to officially open in the first quarter of 2026 and will be managed by Portal Innovations. This initiative aims to support and accelerate the growth of innovative companies in the life sciences sector.

Located in Providence's Innovation District, Ocean State Labs will provide over 30,000 square feet of office and lab space, hosting up to 30 startup companies. The incubator will serve as a hub for entrepreneurs, researchers, and investors, offering the infrastructure and community needed to transform breakthrough ideas into transformative solutions.

The foundational members of Ocean State Labs include companies such as MindImmune Therapeutics, OncoLux Inc., P53 Therapeutics, Pax Therapeutics, and XM Therapeutics. These companies represent a wide range of focus areas within the life sciences, from gene therapy and tissue regeneration to cancer therapeutics and surgical innovation.

The Rhode Island Life Science Hub is backed by an initial $45 million investment from the State of Rhode Island, aiming to build and support a high-impact portfolio of life science startups. By partnering with academic institutions, health systems, and industry leaders, the hub seeks to establish Rhode Island as a nationally recognized center for life science innovation.

We hope you enjoyed this article.

Consider subscribing to one of our newsletters like Life AI Weekly or Daily AI Brief.

Also, consider following us on social media:

Healthcare & Life Sciences AI AI Brief AI Brief (X)

More from: Life Sciences

10/01
Kyruus Health and Healthgrades Partner to Enhance Healthcare Provider Profiles
10/01
SafeTraces Leads $39 Million ARPA-H BREATHE Program for Indoor Air Quality
10/01
New ICD-10 Code Supports AI Sepsis Diagnostic Tools
10/01
Neteera's Monitoring System Shows 77% Sensitivity in Hospitalization Alerts
10/01
Illumina Launches BioInsight to Drive AI-Driven Life Science Discoveries

Subscribe to Life AI Weekly

Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.

AI Token Webinar

Whitepaper

Stanford HAI’s 2025 AI Index Reveals Record Growth in AI Capabilities, Investment, and Regulation

The 2025 AI Index by Stanford HAI provides a comprehensive overview of the global state of artificial intelligence, highlighting significant advancements in AI capabilities, investment, and regulation. The report details improvements in AI performance, increased adoption in various sectors, and the growing global optimism towards AI, despite ongoing challenges in reasoning and trust. It serves as a critical resource for policymakers, researchers, and industry leaders to understand AI's rapid evolution and its implications.

Read more

You May Also Like